Santen Pharmaceutical Co., Ltd. (TYO:4536)
Japan
· Delayed Price · Currency is JPY 1,434.00
+26.50 (1.88%)
Feb 21, 2025, 3:30 PM JST
Santen Pharmaceutical Revenue
Santen Pharmaceutical had revenue of 76.37B JPY in the quarter ending December 31, 2024, a decrease of -0.85%. This brings the company's revenue in the last twelve months to 301.91B, down -0.06% year-over-year. In the fiscal year ending March 31, 2024, Santen Pharmaceutical had annual revenue of 301.97B with 8.22% growth.
Revenue (ttm)
301.91B
Revenue Growth
-0.06%
P/S Ratio
1.68
Revenue / Employee
80.64M
Employees
3,744
Market Cap
489.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 301.97B | 22.93B | 8.22% |
| Mar 31, 2023 | 279.04B | 12.78B | 4.80% |
| Mar 31, 2022 | 266.26B | 16.65B | 6.67% |
| Mar 31, 2021 | 249.61B | 8.05B | 3.33% |
| Mar 31, 2020 | 241.56B | 7.53B | 3.22% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,170.61B |
| Takeda Pharmaceutical Company | 4,579.02B |
| Daiichi Sankyo Company | 1,795.99B |
| HOYA Corporation | 837.44B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,329.86B |
| Astellas Pharma | 1,867.63B |
| Olympus | 993.33B |
Santen Pharmaceutical News
- 2 years ago - Santen Pharmaceutical Co., Ltd. (SNPHY) Management on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha